Elanco Animal Health Inc
Fechado
SetorSaúde
23.98 3.5
Visão Geral
Variação de preço das ações
24h
Mín
23.47
Máximo
24.19
Rendimento | 289M 57M |
|---|---|
Vendas | 227M 1.4B |
P/E Médio do Setor | 372.714 50.958 |
EPS | 0.4 |
Margem de lucro | 4.158 |
Funcionários | 9,400 |
EBITDA | 310M 316M |
Recomendações | Compra Forte |
|---|---|
Previsão para 12 meses | +28% upside |
Próximos Ganhos | 6 de ago. de 2026 |
|---|
Capitalização de Mercado | 696M 12B |
|---|---|
Abertura anterior | 20.48 |
Fecho anterior | 23.98 |
Sentimento de Notícias
By Acuity
8%
92%
8 / 342 Ranking em Healthcare
Elanco Animal Health Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Elanco Animal Health Inc
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.